| 2026-03-13 |
详情>>
内部人交易：
Glickman Sarah JS等共交易4笔
|
| 2026-02-26 |
详情>>
股本变动：
变动后总股本4985.91万股
|
| 2026-02-26 |
详情>>
业绩披露：
2025年年报每股收益2.73美元,归母净利润1.45亿美元,同比去年增长29.61%
|
| 2026-02-11 |
财报披露：
美东时间 2026-02-11 盘前发布财报
|
| 2025-10-29 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.82美元,归母净利润9696.00万美元,同比去年增长139.55%
|
| 2025-07-31 |
详情>>
业绩披露：
2025年中报每股收益1.11美元,归母净利润5917.80万美元,同比去年增长72.88%
|
| 2025-05-02 |
详情>>
业绩披露：
2025年一季报每股收益0.70美元,归母净利润3792.80万美元,同比去年增长423.58%
|
| 2025-04-29 |
股东大会：
将于2025-06-13召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Ms. Rachel Picard as Director,
2.Appoint Stefanie Jay as Director,
3.Ratify the interim appointment of Michael Komasinski as Director decided by the Board of Directors,
4.Non-binding advisory vote to approve the compensation for the named executive officers of the Company,
5.Approve the statutory financial statements for the fiscal year ended December 31, 2024,
6.Approve the consolidated financial statements for the fiscal year ended December 31, 2024,
7.Approve the allocation of results for the fiscal year ended December 31, 2024,
8.Approve the Indemnification Agreement entered into between the Company and Mr. Ernst Teunissen (agreement referred to in Articles L.225-38 et seq. of the French Commercial Code),
9.Approve the Indemnification Agreement entered into between the Company and Mr. Michael Komasinski (agreement referred to in Articles L.225-38 et seq. of the French Commercial Code),
10.Approve the amendment and restatement of the Amended 2016 Stock Option Plan to extend its term,
11.Authorize the Board of Directors to execute a buyback of Company stock in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code,
12.Authorize the Board of Directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the Board of Directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code,
13.Authorize the Board of Directors to reduce the Company’s share capital by cancelling shares acquired by the Company in accordance with the provisions of Article L. 225-208 of the French Commercial Code,
14.Delegate authority to the Board of Directors to reduce the share capital by way of a buyback of Company stock followed by the cancellation of the repurchased stock,
15.Approve the maximum number of shares that may be issued or acquired pursuant to Resolution 16 of the Annual General Shareholders' Meeting dated June 13, 2023 (authorization to grant options to purchase or to subscribe shares), Resolution 15 of the Annual General Shareholders' Meeting dated June 25, 2024 (authorization to grant Time-based RSUs to employees and corporate officers of the Company and employees of its subsidiaries) and Resolution 16 of the Annual General Shareholders' Meeting dated June 25, 2024 (authorization to grant Performance-Based RSUs to employees and corporate officers of the Company and employees of its subsidiaries),
16.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, for the benefit of a category of persons meeting predetermined criteria (underwriters), without shareholders’ preferential subscription rights,
17.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares or any securities giving access to the Company’s share capital through a public offering referred to in paragraph 1 of article L. 411-2 of the French Monetary and Financial Code, without shareholders’ preferential subscription rights,
18.Delegate authority to the Board of Directors to increase the number of securities to be issued as a result of a share capital increase without preserving shareholders' preferential subscription rights pursuant to Resolutions 19 and 20 above ('green shoe'),
19.Delegate authority to the Board of Directors to increase the Company’s share capital through incorporation of premiums, reserves, profits or any other amounts that may be capitalized,
20.Delegate authority to the Board of Directors to increase the Company’s share capital by way of issuing shares and securities giving access to the Company’s share capital for the benefit of members of a Company savings plan (plan d'épargne d’entreprise), without shareholders' preferential subscription rights,
21.Approve the overall limits pursuant to Resolution 19, Resolution 20, Resolution 21, Resolution 22 and Resolution 23 above,
22.Amend Article 12 of the by-laws of the Company entitled “meeting of the Board of Directors” in order to align with new provisions of the French Commercial Code,
23.Amend Article 19 of the by-laws of the Company relating to shareholders meetings in order to comply with new provisions of the French Commercial Code,
24.Amend Article 24 of the by-laws of the Company entitled “Loss of one half of share capital” in order to comply with the new provisions of Article L. 225-248 of the French Commercial Code.
|
| 2025-02-28 |
详情>>
业绩披露：
2024年年报每股收益2.04美元,归母净利润1.12亿美元,同比去年增长109.49%
|
| 2025-02-28 |
详情>>
业绩披露：
2022年年报每股收益0.15美元,归母净利润895.20万美元,同比去年增长-93.34%
|
| 2024-10-30 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.14美元,归母净利润-775.8万美元,同比去年增长-20.32%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.74美元,归母净利润4047.60万美元,同比去年增长621.73%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益0.62美元,归母净利润3423.10万美元,同比去年增长333.10%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益0.13美元,归母净利润724.40万美元,同比去年增长161.34%
|
| 2024-04-26 |
股东大会：
将于2024-06-25召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Ms. Megan Clarken as Director,
2.Renew the term of office of Ms. Marie Lalleman as Director,
3.Renew the term of office of Mr. Edmond Mesrobian as Director,
4.Appoint Ernst Teunissen as Director,
5.Renew RBB Business Advisors as statutory auditor,
6.Non-binding advisory vote to approve the compensation for the named executive officers of the Company,
7.Approve the statutory financial statements for the fiscal year ended December 31, 2023,
8.Approve the consolidated financial statements for the fiscal year ended December 31, 2023,
9.Approve the allocation of profits for the fiscal year ended December 31, 2023,
10.Approve the Indemnification Agreement entered into between the Company and Mr. Frederik van der Kooi (agreement referred to in Articles L.225-38 et seq. of the French Commercial Code),
11.Authorize the Board of Directors to execute a buyback of Company stock in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code,
12.Authorize the Board of Directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the Board of Directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code,
13.Authorize the Board of Directors to reduce the Company’s share capital by cancelling shares acquired by the Company in accordance with the provisions of Article L. 225-208 of the French Commercial Code,
14.Delegate authority to the Board of Directors to reduce the share capital by way of a buyback of Company stock followed by the cancellation of the repurchased stock,
15.Authorize the Board of Directors to grant time-based restricted stock units (“Time-Based RSUs”) to employees and corporate officers of the Company and employees of its subsidiaries pursuant to the provisions of Articles L. 225-197-1 et seq. of the French Commercial Code, without shareholders' preferential subscription rights,
16.Authorize the Board of Directors to grant performance-based restricted stock units (“Performance-Based RSUs”) to employees and corporate officers of the Company and employees of its subsidiaries pursuant to the provisions of Articles L. 225-197-1 et seq. of the French Commercial Code, without shareholders' preferential subscription rights,
17.Approve the maximum number of shares that may be issued or acquired pursuant to Resolution 16 of the Annual General Shareholders' Meeting dated June 13, 2023 (authorization to grant options to purchase or to subscribe shares), Resolution 15 herein (authorization to grant Time-based RSUs to employees and corporate officers of the Company and employees of its subsidiaries) and Resolution 16 herein (authorization to grant Performance-Based RSUs to employees and corporate officers of the Company and employees of its subsidiaries),
18.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, for the benefit of a category of persons meeting predetermined criteria (underwriters), without shareholders’ preferential subscription rights,
19.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, while preserving the shareholders' preferential subscription rights,
20.Delegate authority to the Board of Directors to increase the Company's share capital by issuing ordinary shares or any securities giving access to the Company's share capital through a public offering (excluding offers covered by paragraph 1 of article L. 411-2 of the French Monetary and Financial Code), without shareholders' preferential subscription rights,
21.Delegate authority to the Board of Directors to increase the number of securities to be issued as a result of a share capital increase with or without preserving shareholders' preferential subscription rights pursuant to Resolutions 18, 19 and 20 above ('green shoe'),
22.Delegate authority to the Board of Directors to increase the Company’s share capital by way of issuing shares and securities giving access to the Company’s share capital for the benefit of members of a Company savings plan (plan d'épargne d’entreprise), without shareholders' preferential subscription rights,
23.Approve the overall limits pursuant to Resolution 18 to Resolution 22 above.
|
| 2024-02-23 |
详情>>
业绩披露：
2023年年报每股收益0.95美元,归母净利润5325.90万美元,同比去年增长494.94%
|
| 2023-11-02 |
复牌提示：
2023-11-02 09:30:22 停牌，复牌日期 2023-11-02 09:35:22
|
| 2023-04-27 |
股东大会：
将于2023-06-13召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Rachel Picard as Director;
2.Renew the term of office of Nathalie Balla as Director;
3.Renew the term of office of Hubert de Pesquidoux as Director;
4.Ratification of the appointment of Frederik van der Kooi as Observer;
5.Appointment of Frederik van der Kooi as Director;
6.Renewal of Deloitte & Associés as first principal statutory auditors;
7.Determination of the amount of directors’ remuneration for 2023 and subsequent years;
8.Non-binding advisory vote on the compensation for the named executive officers of the Company;
9.Approval of the statutory financial statements for the fiscal year ended December 31, 2022;
10.Approval of the consolidated financial statements for the fiscal year ended December 31, 2022;
11.Approval of the allocation of profits for the fiscal year ended December 31, 2022;
12.Authorization to be given to the Board of Directors to execute a buyback of Company stock in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
13.Authorization to be given to the Board of Directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the Board of Directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
14.Authorization to be given to the Board of Directors to reduce the Company’s share capital by cancelling shares acquired by the Company in accordance with the provisions of Article L. 225-208 of the French Commercial Code;
15.Delegation of authority to the Board of Directors to reduce the share capital by way of a buyback of Company stock followed by the cancellation of the repurchased stock;
16.Authorization to be given to the board of directors to grant OSAs (options to subscribe for new ordinary shares) or OAAs (options to purchase ordinary shares) of the Company, pursuant to the provisions of Articles L. 225-177 et seq. of the French Commercial Code without shareholders' preferential subscription right;
17.Authorization to be given to the Board of Directors to grant time-based restricted stock units (“Time-Based RSUs”) to employees and corporate officers of the Company and employees of its subsidiaries pursuant to the provisions of Articles L.225-197-1 et seq. of the French Commercial Code, without shareholders' preferential subscription right;
18.Authorization to be given to the Board of Directors to grant performance-based restricted stock units ("Performance-Based RSUs") to employees and corporate officers of the Company and employees of its subsidiaries pursuant to the provisions of Articles L.225-197-1 et seq. of the French Commercial Code from time to time, pursuant to the provisions of Articles L.225-197-1 et seq. of the French Commercial Code, without shareholders' preferential subscription right;
19.Approval of the maximum number of shares that may be issued or acquired pursuant to resolution 16 (authorization to grant options to purchase or to subscribe shares), resolution 17 (authorization to grant Time-Based RSUs to employees and corporate officers of the Company and employees of its subsidiaries) and resolution 18 (authorization to grant Performance-Based RSUs to employees and corporate officers of the Company and employees of its subsidiaries);
20.Delegation of authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, for the benefit of a category of persons meeting predetermined criteria (underwriters), without shareholders’ preferential subscription rights;
21.Delegation of authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares or any securities giving access to the Company’s share capital through a public offering referred to in paragraph 1* of article L. 411-2 of the French Monetary and Financial Code, without shareholders’ preferential subscription rights;
22.Delegation of authority to the Board of Directors to to increase the number of securities to be issued as a result of a share capital increase without preserving shareholders’ preferential subscription rights pursuant to the Twentieth resolution and Twenty-first resolution above (“green shoe”);
23.Delegation of authority to the Board of Directors to increase the Company’s share capital through incorporation of premiums, reserves, profits or any other amounts that may be capitalized;
24.Delegation of authority to the Board of Directors to increase the Company’s share capital by way of issuing shares and securities giving access to the Company’s share capital for the benefit of members of a Company savings plan (plan d’épargne d’entreprise);
25.Approval of the overall limits pursuant to the Twentieth resolution, the Twenty-First resolution, the Twenty-second resolution, the Twenty-third resolution and the Twenty-fourth resolution above;
26.Amendment of Article 15 “Board Observers” of the by-laws.
|
| 2022-04-28 |
股东大会：
将于2022-06-15召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Ms. Megan Clarken as Director;
2.Renew the term of office of Ms. Marie Lalleman as Director;
3.Renew the term of office of Mr. Edmond Mesrobian as Director;
4.Renew the term of office of Mr. James Warner as Director;
5.Non-binding advisory vote to approve the compensation for the named executive officers of the Company;
6.Non-binding advisory vote to hold a non-binding advisory vote on the compensation for the named executive officers of the Company every year;
7.Non-binding advisory vote to hold a non-binding advisory vote on the compensation for the named executive officers of the Company every two years;
8.Non-binding advisory vote to hold a non-binding advisory vote on the compensation for the named executive officers of the Company every three years;
9.Approve the statutory financial statements for the fiscal year ended December 31, 2021;
10.Approve the consolidated financial statements for the fiscal year ended December 31, 2021;
11.Approve the allocation of profits for the fiscal year ended December 31, 2021;
12.Authorize the Board of Directors to execute a buyback of Company stock in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
13.Authorize the Board of Directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the Board of Directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
14.Authorize the Board of Directors to reduce the Company’s share capital by cancelling shares acquired by the Company in accordance with the provisions of Article L. 225-208 of the French Commercial Code;
15.Delegate authority to the Board of Directors to reduce the share capital by way of a buyback of Company stock followed by the cancellation of the repurchased stock;
16.Determine the maximum number of shares that may be issued or acquired pursuant to the authorizations given by the Annual General Shareholders’ Meeting dated June 25, 2020 to grant OSAs (options to subscribe for new Ordinary Shares) or OAAs (options to purchase Ordinary Shares), and to grant time-based restricted stock units (Time-Based RSUs) and performance-based restricted stock units (Performance-Based RSUs) pursuant to resolutions 16 to 18 of the said meeting;
17.Determine the maximum number of shares that may be issued or acquired pursuant to the authorizations given by the Annual General Shareholders’ Meeting dated June 25, 2020 to grant OSAs (options to subscribe for new Ordinary Shares) or OAAs (options to purchase Ordinary Shares), and to grant time-based restricted stock units (Time-Based RSUs) and performance-based restricted stock units (Performance-Based RSUs) pursuant to resolutions 16 to 18 of the said meeting;
18.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing Ordinary Shares, or any securities giving access to the Company’s share capital, while preserving the shareholders’ preferential subscription rights;
19.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing Ordinary Shares, or any securities giving access to the Company’s share capital, through a public offering, without shareholders’ preferential subscription rights;
20.Delegate authority to the Board of Directors to increase the number of securities to be issued as a result of a share capital increase without shareholders’ preferential subscription rights pursuant to items 17 to 19 above (“green shoe”);
21.Delegate authority to the Board of Directors to increase the Company’s share capital by way of issuing shares and securities giving access to the Company’s share capital for the benefit of members of a Company savings plan (plan d'epargne d’entreprise);
22.Approve the overall limits on the amount of Ordinary Shares to be issued pursuant to items 17 to 19, 21 above and 24 below;
23.Delegate authority to the Board of Directors to decide on any merger-absorption, split or partial asset contribution pursuant to the provisions of Article L. 236-9 II of the French Commercial Code;
24.Delegate authority to the Board of Directors to increase the Company’s share capital by way of issuing shares or securities giving access to the Company’s share capital in the scope of a merger-absorption decided by the Board of Directors pursuant to item 23 above.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-06-15召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Ms. Rachel Picard as Director;
2.Renew the term of office of Ms. Nathalie Balla as Director;
3.Renew the term of office of Mr. Hubert de Pesquidoux as Director;
4.Ratify the temporary appointment by the Board of Directors of Ms. Megan Clarken as Director;
5.Non-binding advisory vote to approve the compensation for the named executive officers of the Company;
6.Approve the statutory financial statements for the fiscal year ended December 31, 2020;
7.Approve the consolidated financial statements for the fiscal year ended December 31, 2020;
8.Approve the allocation of profits for the fiscal year ended December 31, 2020;
9.Delegate authority to the Board of Directors to execute a buyback of Company stock in accordance with Article L. 225-209-2 of the French Commercial Code;
10.Delegate authority to the Board of Directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the Board of Directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
11.Authorize the Board of Directors to reduce the Company’s share capital by cancelling shares acquired by the Company in accordance with the provisions of Article L. 225-208 of the French Commercial Code;
12.Delegate authority to the Board of Directors to reduce the share capital by way of a buyback of Company stock followed by the cancellation of the repurchased stock;
13.Approve the maximum number of shares that may be issued or acquired pursuant to the authorizations given to the Board of Directors by the Annual General Meeting dated June 25, 2020 to grant OSAs (options to subscribe for new Ordinary Shares) or OAAs (options to purchase Ordinary Shares), time-based restricted stock units (Time-Based RSUs) and performance-based restricted stock units (Performance-Based RSUs) pursuant to Resolutions 16 to 18 of the Annual General Meeting dated June 25, 2020;
14.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, for the benefit of a category of persons meeting predetermined criteria (underwriters), without shareholders’ preferential subscription rights;
15.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares or any securities giving access to the Company’s share capital through a public offering referred to in paragraph 1° of Article L. 411-2 of the French Monetary and Financial Code, without shareholders’ preferential subscription rights;
16.Delegate authority to the Board of Directors to increase the Company’s share capital through incorporation of premiums, reserves, profits or any other amounts that may be capitalized;
17.Delegate authority to the Board of Directors to increase the number of securities to be issued as a result of a share capital increase without shareholders’ preferential subscription rights pursuant to items 14 and 15 above (“green shoe”);
18.Delegate authority to the Board of Directors to increase the Company’s share capital by way of issuing shares and securities giving access to the Company’s share capital for the benefit of members of a Company savings plan (plan d'épargne d’entreprise);
19.Approve the overall limits on the amount of ordinary shares to be issued pursuant to items 14 to 16 and 18 above;
20.Amend Article 11 of the by-laws of the Company to provide for a Vice-chairperson of the Board of Directors;
21.Amend Article 12.4 of the by-laws of the Company to remove the requirement that an in-person board meeting be held for the dismissal of the CEO for any cause other than willful misconduct;
22.transact such other business as may properly come before the Annual General Meeting or any adjournment or postponement of the Annual General Meeting.
|
| 2020-05-29 |
股东大会：
将于2020-06-25召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Mr. Jean-Baptiste Rudelle as Director;
2.Renew the term of office of Mr. James Warner as Director;
3.Renew the term of office of Mr. Edmond Mesrobian as Director;
4.Renew the term of office of Ms. Marie Lalleman as Director;
5.Approve, on a non-binding advisory basis, the compensation for the named executive officers of the Company;
6.Approve the statutory financial statements for the fiscal year ended December 31, 2019;
7.Approve the consolidated financial statements for the fiscal year ended December 31, 2019;
8.Approve the allocation of profits for the fiscal year ended December 31, 2019;
9.Approve an agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code (Indemnification agreement entered into with Ms. Marie Lalleman);
10.Approve an agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code (Indemnification agreement entered into with Ms. Megan Clarken);
11.Approve an agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code (Consultancy agreement entered into with the company Rocabella);
12.Delegate authority to the board of directors to execute a buyback of Company stock in accordance with Article L. 225-209-2 of the French Commercial Code;
13.Delegate authority to the board of directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the board of directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
14.Authorize the board of directors to reduce the Company’s shares capital by cancelling shares acquired by the Company in accordance with the provisions of Article L. 225-208 of the French Commercial Code;
15.Delegate authority to the board of directors to reduce the share capital by way of a buyback of Company stock followed by the cancellation of the repurchased stock;
16.Authorize the board of directors to grant OSAs (options to subscribe for new Ordinary Shares) or OAAs (options to purchase Ordinary Shares) of the Company, pursuant to the provisions of Articles L. 225-177 et seq. of the French Commercial Code without shareholders' preferential subscription right;
17.Authorize the board of directors to grant time-based restricted stock units to employees and corporate officers of the Company and employees of its subsidiaries pursuant to the provisions of Articles L.225-197-1 et seq. of the French Commercial Code, without shareholders' preferential subscription right;
18.Authorize the board of directors to grant performance-based restricted stock units from time to time to employees and corporate officers of the Company and employees of its subsidiaries pursuant to the provisions of Articles L.225-197-1 et seq. of the French Commercial Code, without shareholders' preferential subscription right;
19.Approve the maximum number of shares that may be issued or acquired pursuant to the authorizations and delegations pursuant to items 16 to 18 above;
20.Delegate authority to the board of directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, while preserving the shareholders’ preferential subscription rights;
21.Delegate authority to the board of directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, through a public offering, without shareholders’ preferential subscription rights;
22.Delegate authority to the board of directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, for the benefit of a category of persons meeting predetermined criteria (underwriters), without shareholders’ preferential subscription rights;
23.Delegate authority to the board of directors to increase the number of securities to be issued as a result of a share capital increase with or without shareholders’ preferential subscription rights pursuant to items 20 to 22 above, and pursuant to the delegation adopted by the 24th Resolution of the Shareholders’ Meeting held on May 16, 2019;
24.Delegate authority to the board of directors to increase the Company’s share capital by way of issuing shares and securities giving access to the Company’s share capital for the benefit of members of a Company savings plan (plan d'épargne d’entreprise);
25.Approve the overall limits on the amount of ordinary shares to be issued pursuant to items 20 to 22 and 24 above and to item 27 below;
26.Delegate authority to the board of directors to decide on any merger-absorption, split or partial asset contribution pursuant to the provisions of Article L. 236-9 II of the French Commercial Code;
27.Delegate authority to the board of directors to increase the Company’s share capital by way of issuing shares or securities giving access to the Company’s share capital in the scope of a merger-absorption decided by the board of directors pursuant to item 26 above;
28.Approve amendment of Article 12 of the by-laws “Board of Directors’ meetings” to comply with the new legal provisions of the French Commercial Code to provide to the board of directors the faculty to take certain decisions by written consultation;
29.Approve amendment of Article 13 of the by-laws “powers of the Board of Directors” to comply with the new provisions of the “Loi Pacte” relating to the attribution of the board of directors;
30.Approve amendment of Article 19 of the by-laws “general shareholders’ meetings” to comply with the new legal provisions of the French Commercial Code relating to the methods of determination of the required majority for the adoption of resolutions by general shareholder’ meetings; and transact such other business as may properly come before the Annual General Meeting or any adjournment or postponement of the Annual General Meeting.
|
| 2019-04-11 |
股东大会：
将于2019-05-16召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Mr. Hubert de Pesquidoux as Director;
2.Renew the term of office of Ms. Nathalie Balla as Director;
3.Renew the term of office of Ms. Rachel Picard as Director;
4.Ratify the provisional appointment of Ms. Marie Lalleman as Director;
5.Approve, on a non-binding advisory basis, the compensation for the named executive officers of the Company;
6.Approve the statutory financial statements for the fiscal year ended December 31, 2018;
7.Approve the consolidated financial statements for the fiscal year ended December 31, 2018;
8.Approve the discharge (quitus) of the members of the board of directors and the statutory auditors for the performance of their duties for the fiscal year ended December 31, 2018;
9.Approve the allocation of profits for the fiscal year ended December 31, 2018;
10.Ratify indemnification agreement entered into with Mr. Jean-Baptiste Rudelle (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code)
11.Approve indemnification agreement entered into with Mr. Benoit Fouilland (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code)
12.Ratify indemnification agreement entered into with Mr. Hubert de Pesquidoux (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code)
13.Ratify indemnification agreement entered into with Mr. James Warner (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code)
14.Ratify indemnification agreement entered into with Ms. Sharon Fox Spielman (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code)
15.Ratify indemnification agreement entered into with Mr. Edmond Mesrobian (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code)
16.Ratify indemnification agreement entered into with Ms. Nathalie Balla (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code)
17.Ratify indemnification agreement entered into with Ms. Rachel Picard (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code)
18.Delegate authority to the board of directors to execute a buyback of Company stock in accordance with Article L. 225-209-2 of the French Commercial Code;
Within the authority of the Extraordinary Shareholders’ Meeting:
19.Delegate authority to the Board of Directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the Board of Directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
20.Approve an amendment to the Company’s By-laws setting the maximum number of Directors;
21.Delegate authority to the board of directors to issue and grant non-employee warrants (bons de souscription d’actions) for the benefit of a category of persons meeting predetermined criteria, without shareholders’ preferential subscription rights;
22.Approve the overall limits on the number of ordinary shares to be issued pursuant to resolution 15 (authorization to grant options to purchase or to subscribe shares), resolution 16 (authorization to grant time-based free shares/restricted stock units to employees of the Company and of its subsidiaries) and resolution 17 (authorization to grant performance-based free shares/restricted stock units to executives and certain employees of the Company and its subsidiaries) adopted by the Annual General Meeting of Shareholders held on June 28, 2017 and Resolution 21 above;
23.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares, or any securities giving access to the Company’s share capital, for the benefit of a category of persons meeting predetermined criteria (underwriters), without shareholders’ preferential subscription rights;
24.Delegate authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares or any securities giving access to the Company’s share capital in the context of a private placement, without shareholders’ preferential subscription rights;
25.Delegate authority to the Board of Directors to increase the number of securities to be issued as a result of a share capital increase pursuant to the delegation in Resolutions 23 and 24 above, with or without shareholders’ preferential subscription rights;
26.Delegate authority to the Board of Directors to increase the Company’s share capital through incorporation of premiums, reserves, profits or any other amounts that may be capitalized;
27.Delegate authority to the board of directors to increase the Company’s share capital by way of issuing shares and securities giving access to the Company’s share capital for the benefit of members of a Company savings plan (plan d'épargne d’entreprise),
|
| 2018-04-30 |
股东大会：
将于2018-06-27召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Mr. Jean-Baptiste Rudelle as Director;
2.Renew the term of office of Ms. Sharon Fox Spielman as Director;
3.Renew the term of office of Mr. Edmond Mesrobian as Director;
4.Renew the term of offic of Mr. James Warner as Director;
5.Approve, on a non-binding advisory basis, the compensation for the named executive officers of the Company;
6.Approve the statutory financial statements for the fiscal year ended December 31, 2017;
7.Approve the consolidated financial statements for the fiscal year ended December 31, 2017;
8.Approve the discharge (quitus) of the members of the board of directors and the statutory auditors for the performance of their duties for the fiscal year ended December 31, 2017;
9.Approve the allocation of profits for the fiscal year ended December 31, 2017;
10.Approve the agreements referred to in Articles L. 225-38 et seq. of the French Commercial Code;
11.Renew the term of office of RBB Business Advisors (previously named Rouer, Bernard, Bretout) as statutory auditor;
12.Delegate authority to the board of directors to execute a buyback of Company stock in accordance with Article L. 225-209-2 of the French Commercial Code.
|
| 2017-04-28 |
股东大会：
将于2017-06-28召开股东大会
会议内容 ▼▲
- 1. Renew the term of office of Mr. Hubert de Pesquidoux as Director;
2. Ratify the provisional appointment of Mr. Edmond Mesrobian as Director;
3. Appoint Ms. Nathalie Balla as Director;
4. Appoint Ms. Rachel Picard as Director;
5. Fix the annual limit for directors’ attendance fees at 2,500,000 (or approximately $2,770,000);
6. Approve, on a non-binding advisory basis, the compensation for the named executive officers of the Company;
7. Approve the statutory financial statements for the fiscal year ended December 31, 2016;
8. Approve the consolidated financial statements for the fiscal year ended December 31, 2016;
9. Approve the discharge (quitus) of the members of the board of directors and the statutory auditors for the performance of their duties for the fiscal year ended December 31, 2016;
10. Approve the allocation of profits for the fiscal year ended December 31, 2016;
11. Approve the agreement relating to the translation of the book written by Jean-Baptiste Rudelle into English (agreement referred to in Article L. 225-38 of the French Commercial Code);
12. Approve the management agreement entered into with Eric Eichmann as Chief Executive Officer (agreement referred to in Article L. 225-38 of the French Commercial Code);
13. Renew the term of office of Deloitte & Associes as principal statutory auditor;
14. Delegate authority to the board of directors to execute a buyback of Company stock in accordance with Article L. 225-209-2 of the French Commercial Code;
Within the authority of the Extraordinary Shareholders' Meeting:
15. Authorize the board of directors to grant OSAs (options to subscribe for new Ordinary Shares) or OAAs (options to purchase Ordinary Shares) of the Company, pursuant to the provisions of Articles L. 225-177 et seq. of the French Commercial Code;
16. Authorize the board of directors to grant time-based free shares / restricted stock units to employees of the Company and its subsidiaries pursuant to the provisions of Articles L. 225-197-1 et seq. of the French Commercial Code;
17. Authorize the board of directors to grant performance-based free shares / restricted stock units to executives and certain employees of the Company and its subsidiaries, from time to time, pursuant to the provisions of Articles L. 225-197-1 et seq. of the French Commercial Code;
18. Delegate authority to the board of directors to issue and grant non-employee warrants (bons de souscription d'actions) for the benefit of a category of persons meeting predetermined criteria, without shareholders' preferential subscription rights;
19. Approve the overall limits on the amount of Ordinary Shares to be issued pursuant to Resolutions 15 to 18 above;
20. Delegate authority to the board of directors to reduce the Company's share capital by cancelling shares as part of the authorization to the board of directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
21. Delegate authority to the board of directors to increase the Company's share capital by issuing Ordinary Shares, or any securities giving access to the Company's share capital, for the benefit of a category of persons meeting predetermined criteria (underwriters), without shareholders' preferential subscription rights;
22. Delegate authority to the board of directors to grant an over-allotment option to increase the number of securities to be issued as a result of a share capital increase pursuant to the delegation in Resolution 21, without shareholders' preferential subscription rights;
23. Delegate authority to the board of directors to increase the Company's share capital through incorporation of premiums, reserves, profits or any other amounts that may be capitalized;
24. Delegate authority to the board of directors to increase the Company's share capital by way of issuing shares and securities giving access to the Company's share capital for the benefit of members of a Company savings plan (plan d'epargne d'entreprise);
25. Amend Article 19 of the Company's By-laws to provide that the record date for attending a shareholders' meeting is two business days prior to such meeting;
26. Amend the Company's By-laws to comply with applicable provisions of the French Commercial Code, including modifications to: (i) Article 4 “Registered Office,” to provide that the Company's registered office may be transferred by the board of directors to any other location in France, (ii) Article 16 “Agreements Subject to Authorization,” to provide that agreements between a company and its wholly-owned subsidiary shall not be characterized as related person agreements that require prior approval of the board of directors, and (iii) Article 18 “Statutory Auditors,” to provide that the Company shall only be required to appoint one or more deputy statutory auditors when required by law;
27. Transact such other business as may properly come before the Annual General Meeting or any adjournment or postponement of the Annual General Meeting.
|
| 2016-04-29 |
股东大会：
将于2016-06-29召开股东大会
会议内容 ▼▲
- 1.Renew the term of office of Mr. Jean-Baptiste Rudelle as Director;
2.Renew the term of office of Mr. James Warner as Director;
3.Ratify the provisional appointment of office of Ms. Sharon Fox Spielman as Director;
4.Renew the term of office of Ms. Sharon Fox Spielman as Director;
5.Appoint Mr. Eric Eichmann as Director;
6.Renew the term of office of Mr. Dominique Vidal, subject to the approval of Resolution 37;
7.Determine the amount of directors’ attendance fees;
8.Approve, on a non-binding advisory basis, the compensation for the named executive officers of the Company;
9.Recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for the named executive officers of the Company every year;
10.Recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for the named executive officers of the Company every two years;
11.Recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for the named executive officers of the Company every three years;
12.Approve the statutory financial statements for the fiscal year ended December 31, 2015;
13.Approve the consolidated financial statements for the fiscal year ended December 31, 2015;
14.Approve the discharge (quitus) of the members of the board of directors and the Statutory Auditors for the performance of their duties for the fiscal year ended December 31, 2015;
15.Approve the allocation of profits for the fiscal year ended December 31, 2015;
16.Approve the agreement relating to the provision of premises and means entered into with The Galion Project (agreement referred to in Article L. 225-38 of the French Commercial Code);
17.Ratify the partnership entered into with The Galion Project (agreement referred to in Article L. 225-38 of the French Commercial Code);
18.Ratify the partnership entered into with France Digitale (agreement referred to in Article L. 225-38 of the French Commercial Code);
19.Delegate authority to the board of directors to execute a buyback of Company stock in accordance with Article L. 225-209-2 of the French Commercial Code;
20.Approve the 2016 Stock Option Plan adopted by the board of directors;
21.Approve the modification to the fungible share ratio in the 2015 Time-Based Free Share/RSU Plan as amended by the board of directors;
22.Approve the modification to the fungible share ratio in the 2015 Performance-Based Free Share/RSU Plan as amended by the board of directors;
23.Authorize the board of directors to grant OSAs (options to subscribe to new ordinary shares) or OAAs (options to purchase ordinary shares) of the Company, pursuant to the provisions of Articles L. 225-177 et seq. of the French Commercial Code, subject to the approval of Resolution 20;
24.Authorize the board of directors to grant time-based free shares/restricted stock units to employees pursuant to the provisions of Articles L.225-197-1 et seq. of the French Commercial Code;
25.Authorize the board of directors to grant performance-based free shares/restricted stock units to executives and certain employees, from time to time, pursuant to the provisions of Articles L.225-197-1 et seq. of the French Commercial Code;
26.Delegate authority to the board of directors to issue and grant non-employee warrants (bons de souscription d’actions) for the benefit of a category of persons meeting predetermined criteria, without shareholders’ preferential subscription rights;
27.Determine the overall limits on the number of ordinary shares to be issued pursuant to Resolutions 23 to 26 above;
28.Delegate authority to the board of directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the board of directors allowing the Company to buy back its own shares in accordance with the provisions of Article L. 225-209-2 of the French Commercial Code;
29.Delegate authority to the board of directors to increase the Company’s share capital by issuing ordinary shares, or any securities granting access to the Company’s share capital, for the benefit of a category of persons meeting predetermined criteria, without shareholders’ preferential subscription rights;
30.Delegate authority to the board of directors to increase the Company’s share capital by issuing ordinary shares, or any securities granting access to the Company’s share capital, through a public offering, without shareholders’ preferential subscription rights;
31.Delegate authority to the board of directors in order to increase the Company’s share capital by issuing ordinary shares, or any securities granting access to the Company’s share capital, in the context of a private placement, without shareholders’ preferential subscription rights;
32.Delegate authority to the board of directors in order to increase the Company’s share capital by issuing ordinary shares, or any securities granting access to the Company’s share capital, while preserving the shareholders’ preferential subscription rights;
33.Delegate authority to the board of directors to increase the number of securities to be issued as a result of a share capital increase pursuant to the delegations in Resolutions 29 to 32, with or without shareholders’ preferential subscription rights;
34.Determine the overall financial limits applicable to the issuances to be completed pursuant to the delegations in Resolutions 29 to 33 and 35;
35.Delegate authority to the board of directors to increase the Company’s share capital by way of issuing shares and securities for the benefit of members of a Company savings plan (plan d’épargne d’entreprise);
36.Amend the quorum requirements for ordinary and extraordinary meetings of the Company’s shareholders, and approve the corresponding amendment to Article 19 of the Company’s By-laws;
37.Reduce the term of office of the directors and observers from three years to two years and approve the corresponding amendment to the Company’s By-laws;
38.Transact such other business as may properly come before the Annual General Meeting or any adjournment or postponement of the Annual General Meeting.
|
| 2015-05-22 |
股东大会：
将于2015-06-23召开股东大会
会议内容 ▼▲
- I.Ordinary Part
1.Approval of the statutory financial statements for the fiscal year ended December 31, 2014
2.Approval of the consolidated financial statements for the fiscal year ended December 31, 2014
3.Discharge (quitus) of the members of the board of directors and the Statutory Auditors for the performance of their duties for the fiscal year ended December 31, 2014
4.Allocation of profits for the fiscal year ended December 31, 2014
5.Approval of the agreements referred to in Articles L.225-38 et seq. of the French Commercial Code
6.Renewal of the term of office of Mrs. Dana Evan as Director
7.Renewal of the term of office of Mr. Hubert de Pesquidoux as Director
8.Delegation of authority to the Board of Directors to execute a buyback of Company stock in accordance with Article L. 225-209-2 of the French Commercial Code
II. Extraordinary Part
9.Delegation of authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares, or any securities granting access to the Company’s share capital, for the benefit of a category of persons meeting predetermined criteria, without shareholders’ preferential subscription rights
10.Delegation of authority to the Board of Directors to increase the Company’s share capital by issuing ordinary shares, or any securities granting access to the Company’s share capital, through a public offering, without shareholders’ preferential subscription rights
11.Delegation of authority to the Board of Directors to increase the number of securities to be issued as a result of a share capital increase pursuant to the delegations in Resolutions 9 and 10, with or without shareholders’ preferential subscription rights
12.Determination of the overall financial limits applicable to the issuances to be completed pursuant to the delegations in Resolutions 9 to 11
13.Delegation of authority to the Board of Directors to increase the Company’s share capital through incorporation of premiums, reserves, profits, or any other amounts that may be capitalized
14.Delegation of authority to the Board of Directors to reduce the Company’s share capital by cancelling shares as part of the authorization to the Board of Directors allowing the Company to buy back its own shares in accordance with the provisions of Article L.225-209-2 of the French Commercial Code
15.Delegation of authority to the Board of Directors to issue and grant warrants (bons de souscription d’actions) for the benefit of a category of persons meeting predetermined criteria, without shareholders’ preferential subscription rights
16.Delegation of authority to the Board of Directors to increase the Company’s share capital by way of issuing shares and securities for the benefit of members of a Company savings plan (plan d'épargne d’entreprise)
|